Akouos Company

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Industry: BioTech
Technology: Neurological Disorders
Funding Status: IPO
Estimated Revenue: $1M to $10M
Headquarters: Boston, Massachusetts, United States
Employee Number: 51-100
Investor Type: For Profit
Total Funding: 137550000
Founded Date: 2017-01-01
Last Funding Type: Series B